Literature DB >> 19834799

Severe prolonged cholestatic hepatitis caused by exemestane.

Ting Bao1, John Fetting, Laura Mumford, Jane Zorzi, Karineh Shahverdi, Stacie Jeter, Frank Herlong, Vered Stearns, Linda Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19834799      PMCID： PMC3085997          DOI： 10.1007/s10549-009-0576-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  14 in total

Review 1.  Drug-induced hepatotoxicity.

Authors:  William M Lee
Journal:  N Engl J Med       Date:  2003-07-31       Impact factor: 91.245

Review 2.  Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis.

Authors:  M A Robin; M Le Roy; V Descatoire; D Pessayre
Journal:  J Hepatol       Date:  1997       Impact factor: 25.083

3.  Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.

Authors:  Francesco Boccardo; Alessandra Rubagotti; Matteo Puntoni; Pamela Guglielmini; Domenico Amoroso; Angela Fini; Giuseppe Paladini; Mario Mesiti; Domenico Romeo; Michela Rinaldini; Simona Scali; Mauro Porpiglia; Chiara Benedetto; Nunzio Restuccia; Franco Buzzi; Roberto Franchi; Bruno Massidda; Vito Distante; Dino Amadori; Piero Sismondi
Journal:  J Clin Oncol       Date:  2005-07-11       Impact factor: 44.544

4.  HLA association of amoxicillin-clavulanate--induced hepatitis.

Authors:  M L Hautekeete; Y Horsmans; C Van Waeyenberge; C Demanet; J Henrion; L Verbist; R Brenard; C Sempoux; P P Michielsen; P S Yap; J Rahier; A P Geubel
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

5.  A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

Authors:  Beat Thürlimann; Aparna Keshaviah; Alan S Coates; Henning Mouridsen; Louis Mauriac; John F Forbes; Robert Paridaens; Monica Castiglione-Gertsch; Richard D Gelber; Manuela Rabaglio; Ian Smith; Andrew Wardley; Andrew Wardly; Karen N Price; Aron Goldhirsch
Journal:  N Engl J Med       Date:  2005-12-29       Impact factor: 91.245

6.  Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.

Authors:  Naga Chalasani; Robert J Fontana; Herbert L Bonkovsky; Paul B Watkins; Timothy Davern; Jose Serrano; Hongqiu Yang; James Rochon
Journal:  Gastroenterology       Date:  2008-09-17       Impact factor: 22.682

7.  A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

Authors:  Paul E Goss; James N Ingle; Silvana Martino; Nicholas J Robert; Hyman B Muss; Martine J Piccart; Monica Castiglione; Dongsheng Tu; Lois E Shepherd; Kathleen I Pritchard; Robert B Livingston; Nancy E Davidson; Larry Norton; Edith A Perez; Jeffrey S Abrams; Patrick Therasse; Michael J Palmer; Joseph L Pater
Journal:  N Engl J Med       Date:  2003-10-09       Impact factor: 91.245

8.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.

Authors:  M Baum; A U Budzar; J Cuzick; J Forbes; J H Houghton; J G M Klijn; T Sahmoud
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

9.  A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.

Authors:  R Charles Coombes; Emma Hall; Lorna J Gibson; Robert Paridaens; Jacek Jassem; Thierry Delozier; Stephen E Jones; Isabel Alvarez; Gianfilippo Bertelli; Olaf Ortmann; Alan S Coates; Emilio Bajetta; David Dodwell; Robert E Coleman; Lesley J Fallowfield; Elizabeth Mickiewicz; Jorn Andersen; Per E Lønning; Giorgio Cocconi; Alan Stewart; Nick Stuart; Claire F Snowdon; Marina Carpentieri; Giorgio Massimini; Judith M Bliss; Cornelius van de Velde
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

Review 10.  American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

Authors:  Eric P Winer; Clifford Hudis; Harold J Burstein; Antonio C Wolff; Kathleen I Pritchard; James N Ingle; Rowan T Chlebowski; Richard Gelber; Stephan B Edge; Julie Gralow; Melody A Cobleigh; Eleftherios P Mamounas; Lori J Goldstein; Timothy J Whelan; Trevor J Powles; John Bryant; Cheryl Perkins; Judy Perotti; Susan Braun; Amy S Langer; George P Browman; Mark R Somerfield
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544
View more
  1 in total

1.  Letrozole-induced hepatitis with autoimmune features: a rare adverse drug reaction with review of the relevant literature.

Authors:  Bharatsinh Gharia; Karan Seegobin; Satish Maharaj; Noor Marji; Amie Deutch; Lara Zuberi
Journal:  Oxf Med Case Reports       Date:  2017-11-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.